Grape King Bio Ltd (1707.TW)
TWD 151.0
(0.0%)
TWD 151.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.49 Billion TWD | -7.23% |
| 2022 | 2.69 Billion TWD | 11.24% |
| 2021 | 2.41 Billion TWD | 1.13% |
| 2020 | 2.39 Billion TWD | -2.66% |
| 2019 | 2.45 Billion TWD | 4.59% |
| 2018 | 2.34 Billion TWD | 4.24% |
| 2017 | 2.25 Billion TWD | 0.91% |
| 2016 | 2.23 Billion TWD | 23.26% |
| 2015 | 1.81 Billion TWD | 13.29% |
| 2014 | 1.59 Billion TWD | 19.22% |
| 2013 | 1.34 Billion TWD | 38.86% |
| 2012 | 966.36 Million TWD | 25.41% |
| 2011 | 770.54 Million TWD | 17.81% |
| 2010 | 654.03 Million TWD | 21.9% |
| 2009 | 536.53 Million TWD | 51.77% |
| 2008 | 353.52 Million TWD | 13.48% |
| 2007 | 311.52 Million TWD | 29.0% |
| 2006 | 241.48 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 551.57 Million TWD | 25.85% |
| 2024 Q1 | 438.28 Million TWD | -46.7% |
| 2023 Q2 | 606.97 Million TWD | 18.77% |
| 2023 Q1 | 511.03 Million TWD | -41.05% |
| 2023 Q4 | 822.3 Million TWD | 20.54% |
| 2023 Q3 | 682.2 Million TWD | 12.39% |
| 2023 FY | 2.49 Billion TWD | -7.23% |
| 2022 Q3 | 672.73 Million TWD | -4.19% |
| 2022 FY | 2.69 Billion TWD | 11.24% |
| 2022 Q2 | 702.12 Million TWD | 56.57% |
| 2022 Q1 | 448.44 Million TWD | -24.83% |
| 2022 Q4 | 866.94 Million TWD | 28.87% |
| 2021 Q3 | 578 Million TWD | 4.69% |
| 2021 FY | 2.41 Billion TWD | 1.13% |
| 2021 Q1 | 413.8 Million TWD | -45.85% |
| 2021 Q2 | 552.12 Million TWD | 33.42% |
| 2021 Q4 | 596.53 Million TWD | 3.21% |
| 2020 Q1 | 467.62 Million TWD | -37.74% |
| 2020 Q3 | 562.42 Million TWD | 10.17% |
| 2020 Q4 | 764.24 Million TWD | 35.88% |
| 2020 Q2 | 510.49 Million TWD | 9.17% |
| 2020 FY | 2.39 Billion TWD | -2.66% |
| 2019 FY | 2.45 Billion TWD | 4.59% |
| 2019 Q3 | 556.42 Million TWD | 0.05% |
| 2019 Q2 | 556.12 Million TWD | 17.98% |
| 2019 Q1 | 471.36 Million TWD | -36.52% |
| 2019 Q4 | 751.08 Million TWD | 34.99% |
| 2018 Q1 | 459.78 Million TWD | -39.32% |
| 2018 Q4 | 742.52 Million TWD | 24.34% |
| 2018 Q3 | 597.17 Million TWD | 8.51% |
| 2018 FY | 2.34 Billion TWD | 4.24% |
| 2018 Q2 | 550.35 Million TWD | 19.7% |
| 2017 Q3 | 545.89 Million TWD | 8.39% |
| 2017 Q1 | 447.06 Million TWD | -29.61% |
| 2017 Q2 | 503.65 Million TWD | 12.66% |
| 2017 Q4 | 757.68 Million TWD | 38.8% |
| 2017 FY | 2.25 Billion TWD | 0.91% |
| 2016 Q1 | 480.06 Million TWD | -9.11% |
| 2016 FY | 2.23 Billion TWD | 23.26% |
| 2016 Q4 | 635.08 Million TWD | 12.24% |
| 2016 Q3 | 565.82 Million TWD | 2.31% |
| 2016 Q2 | 553.04 Million TWD | 15.2% |
| 2015 Q2 | 428.2 Million TWD | 7.4% |
| 2015 Q1 | 398.69 Million TWD | -17.28% |
| 2015 FY | 1.81 Billion TWD | 13.29% |
| 2015 Q4 | 528.17 Million TWD | 15.49% |
| 2015 Q3 | 457.34 Million TWD | 6.8% |
| 2014 Q3 | 401.37 Million TWD | 5.06% |
| 2014 Q2 | 382.06 Million TWD | 11.72% |
| 2014 Q1 | 341.99 Million TWD | -19.54% |
| 2014 FY | 1.59 Billion TWD | 19.22% |
| 2014 Q4 | 481.99 Million TWD | 20.09% |
| 2013 Q4 | 425.07 Million TWD | 18.25% |
| 2013 Q2 | 306.92 Million TWD | 22.6% |
| 2013 FY | 1.34 Billion TWD | 38.86% |
| 2013 Q1 | 250.33 Million TWD | -4.41% |
| 2013 Q3 | 359.45 Million TWD | 17.12% |
| 2012 Q3 | 263.93 Million TWD | 18.66% |
| 2012 Q2 | 222.43 Million TWD | 4.86% |
| 2012 Q1 | 212.11 Million TWD | -11.18% |
| 2012 FY | 966.36 Million TWD | 25.41% |
| 2012 Q4 | 261.87 Million TWD | -0.78% |
| 2011 Q2 | 225.37 Million TWD | 14.91% |
| 2011 Q1 | 196.14 Million TWD | -18.55% |
| 2011 Q4 | 238.82 Million TWD | 116.71% |
| 2011 FY | 770.54 Million TWD | 17.81% |
| 2011 Q3 | 110.2 Million TWD | -51.1% |
| 2010 Q4 | 240.81 Million TWD | 95.86% |
| 2010 FY | 654.03 Million TWD | 21.9% |
| 2010 Q3 | 122.95 Million TWD | -30.08% |
| 2010 Q2 | 175.84 Million TWD | 53.68% |
| 2010 Q1 | 114.42 Million TWD | 0.0% |
| 2009 FY | 536.53 Million TWD | 51.77% |
| 2008 FY | 353.52 Million TWD | 13.48% |
| 2007 FY | 311.52 Million TWD | 29.0% |
| 2006 FY | 241.48 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Standard Chem & Pharm CO., LTD. | 1.25 Billion TWD | -98.218% |
| Maywufa Company Ltd. | 211.01 Million TWD | -1083.147% |
| ScinoPharm Taiwan, Ltd. | 314.49 Million TWD | -693.875% |
| Lotus Pharmaceutical Co., Ltd. | 4.9 Billion TWD | 49.078% |
| LIWANLI Innovation Co., Ltd. | - TWD | -Infinity% |
| YungShin Global Holding Corporation | 929.61 Million TWD | -168.57% |
| PhytoHealth Corporation | -121.67 Million TWD | 2151.879% |
| SCI Pharmtech, Inc. | 160.3 Million TWD | -1457.495% |
| Formosa Laboratories, Inc. | 674.97 Million TWD | -269.89% |
| PharmaEssentia Corporation | - TWD | -Infinity% |
| Bora Pharmaceuticals Co., LTD. | 5.24 Billion TWD | 52.437% |